Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia
Author:
Anna Zuk,Zhihai Si,Sally Loi,Santhosh Bommegowda,Debie Hoivik,Sanjay Danthi,Gyongyi Molnar,Vilmos Csizmadia,Michael Rabinowitz
Publication:
The Journal of Pharmacology and Experimental Therapeutics